BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

Visceral fat A key mediator of steatohepatitis in metabolic liver disease Pages on BioPortfolio:

BioPortfolio - Intra-Abdominal Fat
Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric ... Visceral fat A key mediator of steatohepatitis in metabolic liver disease
...
http://www.bioportfolio.com/indepth/Intra-Abdominal_Fat.html...

BioPortfolio - visceral fat removal 2008
BioPortfolio - Visceral fat A key mediator of steatohepatitis in ... 2008]; Nonalcoholic fatty liver disease in severely obese ... After liver removal ...
http://www.bioportfolio.com/search/visceral_fat_removal_2008...

Results from other life science and pharmaceutical sites:

Visceral fat: a key mediator of steatohepatitis in metabolic liver ...
Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, London R, ...
http://www.ncbi.nlm.nih.gov/pubmed/18627003...

Role of Inflammation in Nonalcoholic Steatohepatitis
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. ... Differential gene expression between visceral and subcutaneous fat depots. ...
http://www.medscape.com/viewarticle/515192_4...

CrossRef Forward Linking Search Results : nature.com
Visceral fat: A key mediator of steatohepatitis in metabolic liver disease. David van der Poorten et al. 48 (2), 2008, p. 449. doi:10.1002/hep.22350 ...
http://www.nature.com/cited/cited.html?doi=10.1038/nature054...

Role of Inflammation in Nonalcoholic Steatohepatitis
22 Nov 2005 ... Next Page: Nonalcoholic Fatty Liver Disease and the Metabolic ... Differential gene expression between visceral and subcutaneous fat depots. ...
http://www.medscape.com/viewarticle/515192...

Visceral fat thickness predicts fatty liver in Kor...[J Korean Med ...
2006]; Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. [Hepatology. 2008]; Ultrasonographic and biochemical evaluation of ...
http://www.ncbi.nlm.nih.gov/pubmed/18437009...

A Model of Insulin Resistance and Nonalcoholic Steatohepatitis in Rats
After liver removal, the epididymal fat was removed to measure visceral adipose ...... G. Insulin resistance: a metabolic pathway to chronic liver disease. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=16...

Evolving trends in nonalcoholic fatty liver diseas...[Eur J Intern ...
2006]; Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. [Hepatology. 2008]; Nonalcoholic fatty liver disease in severely obese
...
http://www.ncbi.nlm.nih.gov/pubmed/18249301...

Nature Clinical Practice Gastroenterology & Hepatology ...
400) of a liver biopsy of a patient with nonalcoholic steatohepatitis. ... Figure 3 Visceral fat and nonalcoholic fatty liver disease: cross-talk between
...
http://www.nature.com/ncpgasthep/journal/v2/n6/full/ncpgasth...

Disease-specific mechanisms of fibrosis: hepatitis C virus and ...
1: Clin Liver Dis. 2008 Nov;12(4):805-24. Disease-specific mechanisms of fibrosis: ... For NASH, the key mediators of damage include oxidative stress,
fat ...
http://www.ncbi.nlm.nih.gov/pubmed/18984468?dopt=Abstract...

Nature Clinical Practice Endocrinology & Metabolism | Nonalcoholic ...
Liver, fat and muscle have key roles in the pathogenesis of insulin resistance. ..... (2005) Mechanisms of disease: adipocytokines and visceral adipose ...
http://www.nature.com/ncpendmet/journal/v3/n6/full/ncpendmet...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.